 | • レポートコード：QY2108PAL8794 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける化学療法誘発性悪心・嘔吐（CINV）治療薬の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、化学療法誘発性悪心・嘔吐（CINV）治療薬の種類別市場規模（5-HT3阻害剤、NK1阻害剤、その他）、用途別市場規模（高催吐性化学療法、中等度催吐性化学療法、低催吐性化学療法、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における化学療法誘発性悪心・嘔吐（CINV）治療薬の種類別市場規模（2016年-2027年）：5-HT3阻害剤、NK1阻害剤、その他 ・世界における化学療法誘発性悪心・嘔吐（CINV）治療薬の用途別市場規模（2016年-2027年）：高催吐性化学療法、中等度催吐性化学療法、低催吐性化学療法、その他 ・化学療法誘発性悪心・嘔吐（CINV）治療薬の中国市場分析 - 化学療法誘発性悪心・嘔吐（CINV）治療薬の中国市場規模（2016年-2027年） - 中国における化学療法誘発性悪心・嘔吐（CINV）治療薬の主要プレイヤー別市場シェア - 中国における化学療法誘発性悪心・嘔吐（CINV）治療薬の種類別市場規模：5-HT3阻害剤、NK1阻害剤、その他 - 中国における化学療法誘発性悪心・嘔吐（CINV）治療薬の用途別市場規模：高催吐性化学療法、中等度催吐性化学療法、低催吐性化学療法、その他 ・化学療法誘発性悪心・嘔吐（CINV）治療薬の北米市場（2016年-2027年） ・化学療法誘発性悪心・嘔吐（CINV）治療薬のヨーロッパ市場（2016年-2027年） ・化学療法誘発性悪心・嘔吐（CINV）治療薬のアジア太平洋市場（2016年-2027年） ・化学療法誘発性悪心・嘔吐（CINV）治療薬の中南米市場（2016年-2027年） ・化学療法誘発性悪心・嘔吐（CINV）治療薬の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Merck、Eisai、Mundipharma、Qilu Pharma、Teva、Novartis、Heron Therapeutics、Roche、Mylan、Tesaro ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs key players include Merck, Eisai, Mundipharma, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share about 50%, followed by China, and Europe both have a share about 35 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%. And in terms of application, the largest application is Moderately Emetogenic Chemotherapy, followed by Highly Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, etc.
Market Analysis and Insights: Global and China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
This report focuses on global and China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market.
In 2020, the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size was US$ 1982 million and it is expected to reach US$ 2659.7 million by the end of 2027, with a CAGR of 4.3% during 2021-2027. In China the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Scope and Market Size
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
5-HT3 Inhibitors
NK1 Inhibitors
Other
Segment by Application
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
1 Study Coverage
1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Type
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Application
1.3.2 Highly Emetogenic Chemotherapy
1.3.3 Moderately Emetogenic Chemotherapy
1.3.4 Low Emetogenic Chemotherapy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2016-2027
2.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2016-2027
2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Region (2022-2027)
3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Competitor Landscape by Players
3.1 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers by Sales
3.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers by Revenue
3.2.1 Key Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue in 2020
3.2.6 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturers
3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type (2016-2021)
4.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021)
4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2021)
4.1.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application (2016-2021)
5.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021)
5.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2021)
5.1.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2016-2021)
5.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2016-2027
6.1.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales YoY Growth 2016-2027
6.1.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue YoY Growth 2016-2027
6.1.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share in Global Market 2016-2027
6.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players by Sales (2016-2021)
6.2.2 China Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players by Revenue (2016-2021)
6.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2016-2021)
6.4 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Type (2022-2027)
6.5 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2016-2021)
6.6 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2016-2027
7.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
7.2.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021)
7.2.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2016-2027
9.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
9.2.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021)
9.2.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
10.2.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021)
10.2.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.1.5 Merck Recent Development
12.2 Eisai
12.2.1 Eisai Corporation Information
12.2.2 Eisai Description and Business Overview
12.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.2.5 Eisai Recent Development
12.3 Mundipharma
12.3.1 Mundipharma Corporation Information
12.3.2 Mundipharma Description and Business Overview
12.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.3.5 Mundipharma Recent Development
12.4 Qilu Pharma
12.4.1 Qilu Pharma Corporation Information
12.4.2 Qilu Pharma Description and Business Overview
12.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.4.5 Qilu Pharma Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Description and Business Overview
12.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.5.5 Teva Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.6.5 Novartis Recent Development
12.7 Heron Therapeutics
12.7.1 Heron Therapeutics Corporation Information
12.7.2 Heron Therapeutics Description and Business Overview
12.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.7.5 Heron Therapeutics Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Description and Business Overview
12.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.8.5 Roche Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Description and Business Overview
12.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.9.5 Mylan Recent Development
12.10 Tesaro
12.10.1 Tesaro Corporation Information
12.10.2 Tesaro Description and Business Overview
12.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.10.5 Tesaro Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
12.11.5 Merck Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends
13.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers
13.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
13.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 5-HT3 Inhibitors
Table 3. Major Manufacturers of NK1 Inhibitors
Table 4. Major Manufacturers of Other
Table 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Regions (2016-2021) & (K Units)
Table 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Regions (2016-2021)
Table 9. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 17. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs as of 2020)
Table 21. Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (2016-2021) (USD/Unit)
Table 22. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Type
Table 24. Date of International Manufacturers Enter into Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) (K Units)
Table 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Type (2016-2021)
Table 28. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Type (2016-2021)
Table 30. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) (K Units)
Table 37. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Application (2016-2021)
Table 38. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Application (2016-2021)
Table 40. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) of Key Companies (2016-2021)
Table 47. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Company (2016-2021)
Table 48. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 49. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Company (2016-2021)
Table 50. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Type (2016-2021)
Table 51. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Type (2016-2021)
Table 52. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Type (2016-2021)
Table 54. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Type (2022-2027)
Table 55. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Type (2022-2027)
Table 56. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Type (2022-2027)
Table 58. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Type (2022-2027)
Table 59. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Application (2016-2021)
Table 60. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Application (2016-2021)
Table 61. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Application (2016-2021)
Table 63. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) by Application (2022-2027)
Table 64. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Application (2022-2027)
Table 65. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Application (2022-2027)
Table 67. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Application (2022-2027)
Table 68. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021) & (K Units)
Table 69. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 70. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2016-2021)
Table 76. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021) & (K Units)
Table 77. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 78. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 80. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 88. Merck Corporation Information
Table 89. Merck Description and Business Overview
Table 90. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 92. Merck Recent Development
Table 93. Eisai Corporation Information
Table 94. Eisai Description and Business Overview
Table 95. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Eisai Product
Table 97. Eisai Recent Development
Table 98. Mundipharma Corporation Information
Table 99. Mundipharma Description and Business Overview
Table 100. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Mundipharma Product
Table 102. Mundipharma Recent Development
Table 103. Qilu Pharma Corporation Information
Table 104. Qilu Pharma Description and Business Overview
Table 105. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Qilu Pharma Product
Table 107. Qilu Pharma Recent Development
Table 108. Teva Corporation Information
Table 109. Teva Description and Business Overview
Table 110. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Teva Product
Table 112. Teva Recent Development
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Business Overview
Table 115. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Novartis Product
Table 117. Novartis Recent Development
Table 118. Heron Therapeutics Corporation Information
Table 119. Heron Therapeutics Description and Business Overview
Table 120. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Heron Therapeutics Product
Table 122. Heron Therapeutics Recent Development
Table 123. Roche Corporation Information
Table 124. Roche Description and Business Overview
Table 125. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Roche Product
Table 127. Roche Recent Development
Table 128. Mylan Corporation Information
Table 129. Mylan Description and Business Overview
Table 130. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Mylan Product
Table 132. Mylan Recent Development
Table 133. Tesaro Corporation Information
Table 134. Tesaro Description and Business Overview
Table 135. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Tesaro Product
Table 137. Tesaro Recent Development
Table 138. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Trends
Table 139. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers
Table 140. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
Table 141. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
Table 142. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers List
Table 143. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Picture
Figure 2. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. 5-HT3 Inhibitors Product Picture
Figure 4. NK1 Inhibitors Product Picture
Figure 5. Other Product Picture
Figure 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2020 & 2027
Figure 7. Highly Emetogenic Chemotherapy
Figure 8. Moderately Emetogenic Chemotherapy
Figure 9. Low Emetogenic Chemotherapy
Figure 10. Other
Figure 11. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Report Years Considered
Figure 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size 2016-2027 (US$ Million)
Figure 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2016-2027 (K Units)
Figure 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2016-2021)
Figure 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region in 2020
Figure 18. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2016-2021)
Figure 19. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region in 2020
Figure 20. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue in 2020
Figure 22. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2021)
Figure 24. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2020
Figure 25. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2016-2021)
Figure 26. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type in 2020
Figure 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2021)
Figure 28. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2020
Figure 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2016-2021)
Figure 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application in 2020
Figure 31. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 32. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players Market Share by Revenue in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in 2020
Figure 35. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Type (2016-2021)
Figure 36. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Application (2016-2021)
Figure 38. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2020
Figure 42. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country in 2020
Figure 43. U.S. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2020
Figure 50. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country in 2020
Figure 51. Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region in 2020
Figure 64. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region in 2020
Figure 65. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 72. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 74. Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 76. Taiwan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 78. Indonesia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 80. Thailand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 82. Malaysia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 84. Philippines Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 86. Vietnam Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 88. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2020
Figure 90. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country in 2020
Figure 91. Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 92. Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 94. Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 96. Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 98. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country in 2020
Figure 101. Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 102. Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 104. Saudi Arabia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. U.A.E Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 106. U.A.E Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
化学療法骨髄抑制治療の世界市場 2020年 Market Overview The global Chemotherapy-Induced Myelosuppression Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …- 化学療法誘発末梢神経障害治療の世界市場 2020年 Market Overview The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pla…
- 化学療法による貧血治療薬の世界市場 2020年 Market Overview The global Chemotherapy Induced Anemia Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chemotherapy…
- 化学療法誘発性好中球減少症治療薬の世界市場 2020年 Market Overview The global Chemotherapy Induced Neutropenia Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chemoth…
- 化学療法輸液ポンプの世界市場 2020年 Market Overview The Chemotherapy Infusion Pumps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…